Author: Adam Feuerstein
Adam Feuerstein
has 91.3% among authors.
BS Score: 10.3%.
Articles analyzed: 1.
Words analyzed: 652.
Analyzed articles
STAT
- By Adam Feuerstein
- 7/1/2026, 11:38 AM
Optimism Bias 50.9% - Attempt to Sell a Product or Service 50.9% - Ambiguity (Equivocation) 42.3%
The Food and Drug Administration on Tuesday approved a personalized T-cell therapy from Orca Bio, a private biotech company, that reduces the risk of a debilitating immune reaction in patients with blood cancers undergoing stem cell transplants. The Orca therapy, called Tregzi, represents an alternative approach to traditional... more
STAT
- By Adam Feuerstein
- 7/1/2026, 8:30 AM
Attempt to Sell a Product or Service 56.5% - Appeal to Authority 25.5% - Negativity Bias 20.9%
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Amylyx Pharmaceuticals: Results from the Phase 3 LUCIDITY study of avexitide in post-bariatric hypoglycemia, a rare metabolic condition that causes severe drops in blood sugar. Biogen: In May, the company announced results from a... more